# Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)

> **NCT01151592** · PHASE4 · WITHDRAWN · sponsor: **American Regent, Inc.**

## Conditions studied

- Iron Deficiency Anemia

## Interventions

- **DRUG:** Iron Sucrose

## Key facts

- **NCT ID:** NCT01151592
- **Lead sponsor:** American Regent, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor Decision
- **Last updated:** 2018-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01151592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01151592, "Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01151592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*